The effects of concurrent administration of (±)3,4-Methylenedioxymethamphetamine and cocaine on conditioned place preference in the adult male rat

Pharmacology Biochemistry and Behavior

Volumn 88, Issue 2, 2007, Pages 165-170

  Diller, Anna J ^a   Rocha, Angelica ^a   Cardon, Aaron L ^a   Valles, Rodrigo ^a   Wellman, Paul J ^a   Nation, Jack R ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

Author keywords

Antagonism; Cocaine; CPP; MDMA

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; COCAINE;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CONDITIONING; CONTROLLED STUDY; DRUG EFFECT; MALE; MOTOR PERFORMANCE; NEUROCHEMISTRY; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; RAT;

ANIMALS; BODY WEIGHT; CHOICE BEHAVIOR; COCAINE; CONDITIONING, OPERANT; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; MALE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; RATS; RATS, SPRAGUE-DAWLEY; REWARD; SEROTONIN;

RATTUS;

EID: 36148970076     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2007.07.017     Document Type: Article

References (52)

1. Aberg M., Wade D., Wall E., and Izenwasser S. Effect of MDMA (ecstasy) on activity and cocaine conditioned place preference in adult and adolescent rats. Neurotoxicol Teratol 29 (2007) 37-46
2. Achat-Mendes C., Anderson K.L., and Itzhak Y. Methylphenidate and MDMA adolescent exposure in mice: long-lasting consequences on cocaine-induced reward and psychomotor stimulation in adulthood. Neuropsychopharmacology 45 (2003) 106-115
3. Armstrong B.D., and Noguchi K.K. The neurotoxic effects of 3,4-methylenedioxymethamphetamine (MDMA) and methamphetamine on serotonin, dopamine, and GABA-ergic terminals: an in-vitro autoradiographic study in rats. Neurotoxicology 25 (2004) 905-914
4. Bardo M.T. Neuropharmacological mechanisms of drug reward: beyond dopamine in the nucleus accumbens. Crit Rev Neurobiol 12 (1998) 37-67
5. Bardo M.T., and Bevins R.A. Conditioned place preference: what does it add to our preclinical understanding of drug reward?. Psychopharmacology 153 (2003) 31-43
6. Bardo M.T., Rowlett J.K., and Harris M.J. Conditioned place preference using opiate and stimulant drugs: a meta-analysis. Neurosci Biobehav Rev 19 (1995) 39-51
7. Battaglia G., Yeh S.Y., and Desouza E.B. MDMA-induced neurotoxicity-parameters of degeneration and recovery of brain-serotonin neurons. Pharmacol Biochem Behav 29 (1998) 269-274
8. Bilsky E.J., Hui Y.Z., Hubbell C.L., and Reid L.D. Methylenedioxymethamphetamines capacity to establish place preferences and modify intake of an alcoholic beverage. Pharmacol Biochem Behav 37 (1990) 633-638
9. Bilsky E.J., Hubbell C.L., Delconte J.D., and Reid L.D. MDMA produces a conditioned place preference and elicits ejaculation in male rats - a modulatory role for the endogenous opioids. Pharmacol Biochem Behav 40 (1991) 443-447
10. Block R.I., Erwin W.J., and Ghoneim M.M. Chronic drug use and cognitive impairments. Pharmacol Biochem Behav 73 (2002) 491-504
11. Calcagnetti D.J., and Schechter M.D. Extinction of cocaine-induced place approach in rats - a validation of the biased conditioning procedure. Brain Res Bull 30 (1993) 695-700
12. Carroll M.E., Lac S.T., Asencio M., and Kragh R. Fluoxetine reduces intravenous cocaine self-administration in rats. Pharmacol Biochem Behav 35 (1990) 237-244
13. Cervo L., Rozio M., Ekalle-Soppo C.B., Carovali F., Santangelo E., and Samanin R. Stimulation of serotonin (1B) receptors induces conditioned place aversion and facilitates cocaine place conditioning in rats. Psychopharmacology 163 (2002) 142-150
14. Clemens K.J., van Niewenhuyzen P.S., Li K.M., Cornish J.L., Hunt G.E., and McGregor I.S. MDMA ("ecstasy"), methamphetamine and their combination: long-term changes in social interaction and neurochemistry in the rat. Psychopharmacology 173 (2004) 318-325
15. Colado M.I., O'Shea E.O., and Green A.R. Acute and long-term effects of MDMA on cerebral dopamine biochemistry and function. Psychopharmacology 173 (2004) 249-263
16. Cole J.C., Sumnall H.R., O'Shea E., and Marsden C.A. Effects of MDMA exposure on the conditioned place preference produced by other drugs of abuse. Psychopharmacology 166 (2003) 383-390
17. Forsyth A.J. Places and patterns of drug use in the Scottish dance scene. Addiction 91 (1996) 511-521
18. Glatz A.C., Ehrlich M., Bae R.S., Clarke M.J., Quinlan P.A., Brown E.C., et al. Inhibition of cocaine self-administration by fluoxetine or d-fenfluramine combined with phentermine. Pharmacol Biochem Behav 71 (2002) 197-204
19. Green A.R., Cross A.J., and Goodwin G.M. Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or "Ecstasy"). Psychopharmacology 119 (1995) 247-260
20. Gross S.R., Barrett S.P., Shestowsky J.S., and Pihl R.O. Ecstasy and drug consumption patterns: a Canadian rave population study. Can J Psychiatry 47 (2002) 546-551
21. Hall F.S., Sora I., Drgonova J., Li X.F., Goeb M., and Uhl G.R. Molecular mechanisms underlying the rewarding effects of cocaine. Ann N Y Acad Sci 1025 (2004) 47-56
22. Harkin A., Connor T.J., Mulrooney J., Kelly J.P., and Leonard B.E. Prior exposure to methylenedioxyamphetamine (MDMA) induces serotonergic loss and changes in spontaneous exploratory and amphetamine-induced behaviors in rats. Life Sci 68 (2001) 1367-1382
23. Heidbreder C.A., Thompson A.C., and Shippenberg T.S. Role of extracellular dopamine in the initiation and long term expression of behavioral sensitization to cocaine. J Pharmacol Exp Ther 278 (1996) 490-502
24. Horan B., Gardner E.L., and Ashby C.R. Enhancement of conditioned place preference response to cocaine in rats following subchronic administration of 3,4-methylenedioxymethamphetamine (MDMA). Synapse 35 (2000) 160-162
25. Howell L.L., and Byrd L.D. Serotonergic modulation of the behavioral effects of cocaine in the squirrel monkey. J Pharmacol Exp Ther 275 (1995) 1551-1559
26. Johansen P.A., Hu X.T., and White F.J. Relationship between D1 dopamine receptors, adenylate cyclase, and the electrophysiological responses of rat nucleus accumbens neurons. J Neural Transm 86 (1991) 97-113
27. Kalivas P.W., and Duffy P. Time course of the extracellular dopamine and behavioral sensitization to cocaine. I. Dopamine axon terminals. J Neurosci 13 (1993) 266-275
28. Knapp C.M., Printseva B., Cottam N., and Kornetsky C. Effects of cue exposure on brain glucose utilization 8 days after repeated cocaine administration. Brain Res 950 (2002) 119-126
29. Loh E.A., and Roberts D.C.S. Break-points on a progressive ratio schedule reinforced by intravenous cocaine increase following depletion of forebrain serotonin. Psychopharmacology 101 (1990) 262-266
30. McKenna D.J., and Peroutka S.J. Neurochemistry and neurotoxicity of 3,4, methylenedioxymethamphetamine (MDMA, 'ecstasy'). J Neurochem 54 (1990) 14-22
31. Miller D.K., and Nation J.R. Chronic cadmium exposure attenuates the conditioned reinforcing properties of morphine and fentanyl. Brain Res 776 (1997) 162-169
32. Miller D.K., Nation J.R., and Bratton G.R. Perinatal exposure to lead attenuates the conditioned reinforcing properties of cocaine in male rats. Pharmacol Biochem Behav 67 (2000) 111-119
33. Miller D.K., Palme K.M., Najvar S.A., Caudill S.D., and Nation J.R. Chronic cadmium exposure attenuates conditioned place preference produced by cocaine and other drugs. Pharmacol Biochem Behav 64 (1990) 15-20
34. 1A receptors. Prog Neurobiol 81 (2007) 133-178
35. Obradovic T., Imel K.M., and White S.R. Repeated exposure to methylenedioxymethamphetamine (MDMA) alters nucleus accumbens neuronal responses to dopamine and serotonin. Brain Res 785 (1998) 1-9
36. Parrott A.C., Sisk E., and Turner J.J. Psychobiological problems in heavy "ecstasy" (MDMA) polydrug users. Drug Alcohol Depend 60 (2000) 105-110
37. Peroutka S.J. Incidence of recreational use of 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") on an undergraduate campus. N Engl J Med 317 (1987) 1542-1543
38. Pettit H.O., Pan H.T., Parsons L.H., and Justice J.B. Extracellular concentrations of cocaine and dopamine are enhanced by chronic administration. J Neurochem 55 (1990) 798-804
39. Phillips A.G. Brain reward circuitry: a case for separate systems. Brain Res Bull 12 (1984) 195-201
40. Rattray M. Ecstasy: towards an understanding of the biochemical basis of the actions of MDMA. Essays Biochem 26 (1991) 77-87
41. Riley A.L. Use of drug discrimination learning in behavioral toxicology: classification and characterization of toxins. In: Chang L.W., and Slikker Jr. W. (Eds). Neurotoxicology: approaches and methods (1995), Academic Press, San Diego, CA 309-321
42. Ritz M.C., and Kuhar M.J. Relationship between self-administration of amphetamine and monoamine receptors in brain: comparison with cocaine. J Pharmacol Exp Ther 248 (1989) 1010-1017
43. Rothman R.B., and Baumann M.H. Monoamine transporters and psychostimulant drugs. Eur J Pharmacol 479 (2003) 23-40
44. Schechter M.D. Effect of MDMA neurotoxicity upon its conditioned place preference and discrimination. Pharmacol Biochem Behav 38 (1991) 539-544
45. Schenk S., Gittings D., Johnstone M., and Daniela E. Development, maintenance and temporal pattern of self-administration maintained by ecstasy (MDMA) in rats. Psychopharmacology 169 (2003) 21-27
46. Smit F., Monshouwer K., and Verdurmen J. Polydrug use among secondary school students: combinations, prevalences and risk profiles. Drugs Educ Prev Policy 9 (2002) 355-365
47. Smith K.R., and Nation J.R. Developmental exposure to cadmium alters responsiveness to cocaine in the rat. Drug Alcohol Depend 72 (2003) 1-11
48. Smith F.L., Yu D.S., Smith D.G., Leccese A.P., and Lyness W.Y. Dietary tryptophan supplements attenuate amphetamine self-administration in the rat. Pharmacol Biochem Behav 25 (1986) 849-855
49. Uhl G.R., Hall F.S., and Sora I. Cocaine, reward, movement and monoamine transporters. Mol Psychiatry 7 (2002) 21-26
50. Undie A.S., and Freidman E. Stimulation of a dopamine D1 receptor enhances inositol phosphates formation in rat brain. J Pharmacol Exp Ther 253 (1990) 987-992
51. Wee K.G., Anderson M.H., Bauman M.H., Rothman R.B., Blough B.E., and Woolverton W.L. Relationship between the serotonergic activity and reinforcing effects of a series of amphetamine analogs. J Pharmacol Exp Ther 313 (2005) 848-854
52. White S.R., Duffy P., and Kalivas P.W. Methylenedioxymethamphetamine depresses glutamate-evoked neuronal firing and increases extracellular levels of dopamine and serotonin in the nucleus accumbens in vivo. Neuroscience 62 (1994) 41-50